CURRENT
STUDIES
AGITATION IN DEMENTIA
CLINICAL TRIAL
Mercury Clinical Research is seeking adult volunteers to participate in a study to evaluate the efficacy, safety, and tolerability of an investigational medication in the treatment of patients with Agitation in associated with Dementia of the Alzheimer’s type.
Be assured that all information is kept strictly confidential per HIPAA regulations, FDA laws, and the American Medical Association ethical guidelines. Compensation may be provided to those that qualify in the study.
This trial is currently enrolling.
TO QUALIFY
-
Patient must be between 55 and 90 years of age
-
Patient must have a diagnosis of probable Alzheimer’s disease and Agitation
-
Patient must have a previous MRI or CT scan of the brain that was performed after the onset of the symptoms of Dementia, with findings consistent with a diagnosis of Alzheimer’s Disease
PROVIDED AT NO COST
-
Medical Procedures
-
Physical Examinations
-
Physician Visits
-
Laboratory Tests
-
Medicine
NO INSURANCE NEEDED
If you would like to receive more information about the clinical trial, please, fill out the form below. One of our Research Coordinators will get back to you within 24 hours.
